METHODS: This retrospective study was conducted in pediatric patients (<18 years) who underwent TAE for blunt trauma between February 2014 and July 2022. The patients were categorized into subgroups based on age and body weight. Patient demographics, injury severity, transfusion requirements, and clinical outcomes were analyzed.
RESULTS: Exactly 73 patients underwent TAE. Technical success was achieved in all patients (100%), and clinical success was achieved in 83.6%. The mortality and complication rates were 4.1% and 1.4%, respectively. The mean duration of hospitalization was 19.3 days. Subgroup analysis showed that age, body weight, and sex did not significantly affect clinical success. The injury severity score and transfusion requirement were predictors of clinical success, with lower values associated with better outcomes.
CONCLUSIONS: TAE is effective and safe for managing blunt pediatric trauma in younger and lighter patients. Injury severity and transfusion requirement are predictors of clinical success.
方法:这项回顾性研究是在2014年2月至2022年7月期间因钝性创伤而接受TAE的儿科患者(<18岁)中进行的。根据年龄和体重将患者分为亚组。患者人口统计学,损伤严重程度,输血要求,并对临床结局进行分析。
结果:正好73例患者接受了TAE。所有患者均取得技术成功(100%),临床成功率为83.6%。死亡率和并发症发生率分别为4.1%和1.4%,分别。平均住院时间为19.3天。亚组分析显示,年龄,体重,性别对临床成功率无显著影响.损伤严重程度评分和输血需求是临床成功的预测因素,较低的值与更好的结果相关。
结论:TAE对于处理较年轻和较轻的儿童钝性创伤是有效和安全的。损伤严重程度和输血需求是临床成功的预测因素。